Caribou Biosciences (CRBU) EBITDA Margin (QoQ) (2020 - 2026)
Caribou Biosciences (CRBU) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Caribou Biosciences | 163.09 Mn | 50.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -59,402.00 |
| Mar 31, 2026 | -37,440.00 |
| Dec 31, 2025 | 61,561.00 |
| Sep 30, 2025 | 44,637.00 |
| Jun 30, 2025 | 3,980.00 |
| Mar 31, 2025 | 4,793.00 |
| Dec 31, 2024 | 1,754.00 |
| Sep 30, 2024 | -63,343.00 |
| Jun 30, 2024 | 63,806.00 |
| Mar 31, 2024 | -84,153.00 |
| Dec 31, 2023 | -99,049.00 |
| Sep 30, 2023 | 81,347.00 |
| Jun 30, 2023 | 1,321.00 |
| Mar 31, 2023 | -6,030.00 |
| Dec 31, 2022 | -2,480.00 |
| Sep 30, 2022 | -12,520.00 |
| Jun 30, 2022 | 10,455.00 |
| Mar 31, 2022 | 1,461.00 |
| Dec 31, 2021 | -32,929.00 |
| Sep 30, 2021 | 61,348.00 |